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CASE REPORTSerpiginous mycosis fungoides in a 21-year-old man
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MF: mycosis fungoidesINTRODUCTION
Mycosis fungoides (MF) is a common type of
cutaneous non-Hodgkin mature T cell lymphoma
(CTCL). The median age of diagnosis is in the
mid-50s with an increased incidence seen in patients
older than 70.1 Before the diagnosis of MF, patients
may experience a premycotic phase, during which
nonspecific scaly skin lesions are present. These may
fluctuate and resemble more common skin
conditions, such as eczema and psoriasis, rendering
a definitive diagnosis difficult to establish. Further
complicating matters, MF may present with a variety
of morphologically distinct cutaneous lesions. In
addition to the classic form of MF, there are 3
other common variants: folliculotropic, pagetoid
reticuloid, and granulomatous cutis laxa. More rare
subtypes include, among others, hypopigmented/
hyperpigmented, erythrodermic, poikilodermic, pig-
mented purpuralike, bullous/dyshidrotic, papular,
and the invisible subtypes.2 These cutaneous lesions
may be pruritic and have a profound impact on a
patient’s quality of life.3 Because of the nonspecific
and variable course of presentation, the diagnosis of
MF usually takes many years.1
We present a case of MF in a young adult Asian
male with an atypical presentation.CASE REPORT
A previously healthy 21-year-old Asian man
presented with a 4-year history of nonpruritic,
hyperpigmented lesions that initially started as small,
eczemalike, erythematous papules on his legs. After
clinical and histologic evaluations by numerous
dermatologists, these lesions were initially diag-
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progress despite topical corticosteroids, so his family
physician referred him to our clinic for evaluation
and treatment. During his initial consultation with us,
he reported no systemic symptoms, joint pain, or
shortness of breath and appeared well and healthy.
Family history was significant for leukemia in his
grandfather. There was no personal or family history
of eczema or atopy. Interestingly, he was assessed
for possible Lisch nodules and cafe au lait macules in
2000 but did not meet criteria for a diagnosis of
neurofibromatosis type I. Other than a remote
history of a slight partial thromboplastin time
elevation, which was deemed nonsignificant by his
hematologist, his medical history was unremarkable.
He was not on any medications nor did he have any
allergies.
Examination found large annular to serpiginous,
polycyclic, brown, nonscaly patches with mild
atrophy and a rim of hyperpigmentation on his limbs
(Fig 1). Numerous ecchymoses and red/brown 1- to
2-mm papules and macules on his legs were noted.
Punch biopsies of 3 separate areas taken from both
legs showed a perivascular and bandlike infiltrate of
lymphocytes, histiocytes, and melanophages within
a papillary dermis that was fibrotically thickened.
There was an increased number of atypical
lymphocytes with irregularly shaped hyperchro-
matic nuclei, arranged singly, within the basal cell
region of an epidermis in which there was noJAAD Case Reports 2015;1:82-4.
2352-5126
 2015 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
http://dx.doi.org/10.1016/j.jdcr.2015.01.009
Fig 1. MF: the patient presented with these annular, serpiginous, hyperpigmented lesions on
his limbs. A, Right knee. B, Posterior aspect of lower limbs. C, Left forearm.
Fig 2. Hematoxylin and eosin stain shows lymphocytic
infiltration and an increased number of atypical
lymphocytes, with irregularly-shaped hyperchromatic
nuclei within the basal cell region of the epidermis.
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stain was negative for fungi.
These findings were consistent with that of
cutaneous T-cell lymphoma.
The patient responded well to treatment with
narrow band ultraviolet B therapy 3 times weekly,
showing partial resolution of his lesions after 8
weeks of treatment.
DISCUSSION
The etiology of MF is poorly understood; how-
ever, associations with human T-lymphocyte virus Ihave been made.1 It is thought that continuous
activation of cutaneous T-helper lymphocytes leads
to malignant transformation of a specific clone.4 A
recent meta-analysis found an increased risk of MF
associated with body mass index equal to or larger
than 30 kg/m2, cigarette smoking for 40 years or
more, eczema, and family history of multiple
myeloma.5 Other possible risk factors that have
been implicated include drugs, infections, radiation,
and chemical exposure, especially aromatic
halogenated hydrocarbons and pesticides.4 MF can
be diagnosed using a combination of clinical
impression and histopathology, but the diagnosis
often is not made until a few years after the onset
after numerous skin biopsies. Immunophenotyping
and polymerase chain reaction can also be used to
aid in diagnosis.1
MF is more common among older individuals,
with a male preponderance. MF in patients younger
than 35 years is rare and even more unusual in
patients younger than 25 years, although cases even
in infants have been reported.6 Nevertheless, the
young age at onset seen in our patient is somewhat
uncommon. Our initial differential diagnosis of his
cutaneous eruption included, among others,
granuloma annulare, sarcoidosis, annular lichen
planus, annular psoriasis, and partially treated atopic
dermatitis.
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is rare. A literature search found only 1 case of MF in a
61-year-old man with a 30-year history of serpiginous
eruption on his limbs.7 We came across 1 published
case of MF presenting as ecchymosislike, hyperpig-
mented mycosis fungoides.8 We were able to find
about 20 cases of purpuric MF, with most cases
reported in patients in their teens or early 20s.9-12
Similarly, searching for arcuate or polycyclicMF/CTCL
yielded several reports. However, having purpuric/
ecchymotic, arcuate/polycyclic, and serpiginous fea-
tures in a single patient was rare.
At first glance, the lesions in our patient may
resemble erythema annulare centrifugum (EAC). We
found 9 previous reports of EAC-like MF, with most
cases arising in patients older than 40.13-21 Only a few
cases of EAC-like MF were found in individuals
younger than 30 years.13,14,17 The youngest reported
MF resembling EAC was in a 12-year-old girl.17 The
constellation of features—hyperpigmentation, EAC-
like figurate/serpiginous, and ecchymotic/purpuric
lesions in a patient with darker complexion—makes
this case unique.
The prognosis for MF is generally good, especially
in patients with patch/plaque stage, but median sur-
vival rates decrease in patients with more advanced
disease. Furthermore, the frequency of large cell
transformation to a more aggressive clinical form of
CTCL increases with advancing clinical stage of MF. It
is, therefore, important to identify MF early so that
appropriate therapies could be instituted to reduce
potential progression and subsequent complications.
The authors thank Dr. Henry Jakubovic for providing
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